cannabinoids

Biotech

Cannabinoid-focused drugmaker InMed backs away from H&W sector

Jumping into the health and wellness sector once seemed like an easy win for some pharma companies, but tough times are extending beyond biotech.
James Waldron Sep 9, 2022 7:45am

Anebulo drug reduces cannabinoid intoxication in phase 2 study

Jul 5, 2022 12:39pm

Cannabidiol shows promise against superbugs

Jun 24, 2019 12:11pm

Corbus nets over 600 cannabinoid compounds, to test 1-2 per year

Sep 20, 2018 9:32am

Auxly Cannabis to acquire CRO KGK for $12.3M

Aug 29, 2018 12:50pm

GB Sciences to test cannabis-based therapies in humans

Jul 18, 2017 4:46pm